SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: notyet who wrote (1819)3/15/1999 7:29:00 PM
From: Linda Pearson  Read Replies (1) of 2135
 
Boston Life Compound Halts Growth of Spreading Tumors in Mice

news.com^2FGene~ENMD~BLO~41136805~~~~~,00.html

<Researchers found that twice-a-week doses of the compound, a
protein called Troponin I, were effective against cancer that had
metastasized, or spread, and begun to form tumors in the lungs of
the mice in the study.

The study was released after the close of trading on U.S.
markets and appears in tomorrow's edition of the Proceedings of
the National Academy of Sciences.>

<Separately today in the Proceedings of the National Academy
of Science, Duke University researchers presented a study
explaining why one well known angiogenesis blocker has the effect
it does.

Angiostatin, under development at EntreMed, latches onto and
inactivates an enzyme which supplies the energy needed for vessel
growth, the Duke team said.>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News